Jiangxi Fushine Pharmaceutical Plans to Increase VC Product Capacity to 10,000 Tons/Year Through Technical Upgrades, Expected Completion by Q2 2026

Deep News
Nov 16, 2025

Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ) disclosed in its investor relations activity report that, according to Wind data, the price of VC products has remained around RMB 50,000 per ton over the past two years. Recently, VC prices have surged rapidly, driven by strong demand growth in energy storage batteries, power batteries, as well as macroeconomic policies and industry supply-demand dynamics.

Currently, the company has an annual production capacity of 8,000 tons for VC products and approximately 4,000 tons for FEC products. It plans to expand VC production capacity to 10,000 tons per year through technical upgrades, with the project expected to be completed by the second quarter of 2026. Depending on market demand and industry capacity expansion, the company may further increase VC and FEC production capacities to 20,000 tons and 5,000 tons per year, respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10